Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Baker

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
JAMA|January 25, 2007
Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trialFrançois Lespérance, Nancy Frasure-Smith, Diana Koszycki, et al.
Journal of the American College of Cardiology|May 4, 2004
The influence of age, gender, and race on the prevalence of depression in heart failure patientsStephen S Gottlieb, Meenakshi Khatta, Erika Friedmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 6, 2020
Pharmacologic Characterization of ALD403, a Potent Neutralizing Humanized Monoclonal Antibody Against the Calcitonin Gene-Related PeptideLeon F Garcia-Martinez, Carol J Raport, Ethan W Ojala, et al.
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|June 4, 2019
Low-Dimensional Metal-Organic Coordination Structures on GrapheneJun Li, Leonid Solianyk, Nico Schmidt, et al.
JCO Precision Oncology|September 24, 2025
Clinical Interchangeability of PD-L1 Immunohistochemistry Assays in First-Line Non-Small Cell Lung Cancer Management With CemiplimabJavier Perez, Keith M Kerr, Brian Baker, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 7, 2016
Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS studyJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Chemistry & Biology|May 5, 2004
Systems-based design of bi-ligand inhibitors of oxidoreductases: filling the chemical proteomic toolboxDaniel S Sem, Bonnie Bertolaet, Brian Baker, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 19, 2018
Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for AtezolizumabBharathi Vennapusa, Brian Baker, Marcin Kowanetz, et al.
Endocrinology|December 2, 2016
ALD1613, a Novel Long-Acting Monoclonal Antibody to Control ACTH-Driven PharmacologyAndrew L Feldhaus, Katie Anderson, Benjamin Dutzar, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 16, 2019
Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating PeptideCristina Moldovan Loomis, Benjamin Dutzar, Ethan W Ojala, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
JAMA|January 25, 2007
Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trialFrançois Lespérance, Nancy Frasure-Smith, Diana Koszycki, et al.
Journal of the American College of Cardiology|May 4, 2004
The influence of age, gender, and race on the prevalence of depression in heart failure patientsStephen S Gottlieb, Meenakshi Khatta, Erika Friedmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 6, 2020
Pharmacologic Characterization of ALD403, a Potent Neutralizing Humanized Monoclonal Antibody Against the Calcitonin Gene-Related PeptideLeon F Garcia-Martinez, Carol J Raport, Ethan W Ojala, et al.
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|June 4, 2019
Low-Dimensional Metal-Organic Coordination Structures on GrapheneJun Li, Leonid Solianyk, Nico Schmidt, et al.
JCO Precision Oncology|September 24, 2025
Clinical Interchangeability of PD-L1 Immunohistochemistry Assays in First-Line Non-Small Cell Lung Cancer Management With CemiplimabJavier Perez, Keith M Kerr, Brian Baker, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 7, 2016
Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS studyJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Chemistry & Biology|May 5, 2004
Systems-based design of bi-ligand inhibitors of oxidoreductases: filling the chemical proteomic toolboxDaniel S Sem, Bonnie Bertolaet, Brian Baker, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 19, 2018
Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for AtezolizumabBharathi Vennapusa, Brian Baker, Marcin Kowanetz, et al.
Endocrinology|December 2, 2016
ALD1613, a Novel Long-Acting Monoclonal Antibody to Control ACTH-Driven PharmacologyAndrew L Feldhaus, Katie Anderson, Benjamin Dutzar, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 16, 2019
Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating PeptideCristina Moldovan Loomis, Benjamin Dutzar, Ethan W Ojala, et al.
Pageof 6